Clinical neurology

Championing bench-to-bedside research

The Division of Neurology is dedicated to delivering world-leading research that advances our understanding of neurological disease and translates scientific discoveries into meaningful improvements in patient care. By bridging the gap between laboratory science and clinical practice, we aim to develop innovative diagnostic tools, treatments, and healthcare interventions that improve outcomes for individuals living with neurological disorders.

Our Division brings together internationally recognised non-clinical scientists, clinician scientists, and academic neurologists working across a broad spectrum of research areas, including epilepsy, stroke, Parkinson’s disease, dementia, multiple sclerosis, motor neuron disease, and neurogenetic and neuroinflammatory disorders.

Through multidisciplinary collaboration and the application of cutting-edge approaches spanning molecular and cellular neuroscience, genetics, neuroimaging, computational biology, clinical trials, and population health research, we seek to address some of the most pressing challenges in neurology.

Research areas include:


Principal Investigators

Professor Paresh Malhotra

Dr Javier Alegre Abarrategui

Professor Praveen Anand

Dr Wenjia Bai

Dr Peter Bain

Dr Peter Bain
Reader in Clinical Neurological Medicine

Professor Payam Barnaghi

Dr Paul Bentley

Professor Adolfo Bronstein

Dr Christopher Butler

Professor Paul Edison

Dr Toby Ellmers

Dr Fatemeh Geranmayeh

Professor Roger Gunn

Professor Michael Johnson

Dr Lucia Li

Professor Paul Matthews

Professor Paolo Muraro

Professor Richard Nicholas

Professor David Owen

Professor Paola Piccini

Dr Gregory Scott

Professor David Sharp

Dr Yen F Tai

Professor Sudhin Thayyil

Professor Roland Veltkamp

Dr Alastair Webb

Dr Neil Graham

Dr Stephen Auger

We are equally committed to fostering an inclusive, diverse, and supportive environment where talented individuals from all backgrounds can thrive, collaborate, and contribute. By combining excellence in research with a culture of openness, innovation, and mutual respect, we create the conditions for scientific discovery to flourish. Through strong partnerships with NHS organisations, research institutes, industry, and international collaborators, we are driving the development of novel therapies and pioneering new approaches to the prevention, diagnosis, and treatment of neurological disease.

General enquiries

wbcn-enquiries@imperial.ac.uk